Advertisement

Topics

Gerot Pharmazeutika Company Profile

10:21 EDT 21st September 2017 | BioPortfolio

1948 Gerot Pharmazeutika is founded by two chemists, Dr. Gergely and Dr. Otto.
1952 First patent granted on the newly developed product Epilan.

1965 Start of the production and sales of X-ray contrast media licensed from Bracco, Italy

1977 Start of the export activities in Eastern European countries. Later Gerot founds its own subsidiaries e.g.:

1991 Hungary

1992 Poland

1994 Czech Republic and Slovakia

1999 Romania

1992 Gerot becomes part of Donauchemie, which belongs to the Rhône-Poulenc S.A. group, and is in charge of marketing the products of Rhône-Poulenc Rorer in Austria.

1997 Again in private hands Gerot becomes an independent associate company of the Austrian pharmaceutical company Lannacher Heilmittel GmbH.

Location

Arnethgasse 3
Vienna
A-1160
Austria

Contact

Phone: 43 (0)1 485 35 05
Fax: 43 (0)1 485 77 73
Email: sabine.mucila@gerot.co.at


News Articles [10 Associated News Articles listed on BioPortfolio]

Sanochemia Pharmazeutika AG zahlt Anleihe 2012/17 vollends zurück

Pressemitteilung der Sanochemia Pharmazeutika AG: Die Sanochemia Pharmazeutika AG, Wien (ISIN AT0000776307, ISIN DE000A1G7JQ9) gibt bekannt, dass die Anleihe 2012/17 in Höhe von EURO 10 Millionen, .....

PTA-News: SANOCHEMIA Pharmazeutika AG: Tolperison USA: Start der klinischen Phase I-Studie

Unternehmensmitteilung für den Kapitalmarkt Wien (pta015/11.09.2017/10:00) - Die börsennotierte Sanochemia Pharmazeutika AG, Wien (ISIN AT0000776307, ISIN DE000A1G7JQ9), gibt den Beginn der, vom Pa....

SANOCHEMIA Pharmazeutika: Endfälligkeit der Anleihe 2012/17 - Anleihenews

Bad Marienberg - Die Sanochemia Pharmazeutika AG, Wien (ISIN AT0000776307/ WKN 919963, Anleihe: ISIN DE000A1G7JQ9/ WKN A1G7JQ) gibt bekannt, dass die Anleihe 2012/17 in Höhe von EURO 10 Millionen, .....

PTA-News: SANOCHEMIA Pharmazeutika AG: Endfälligkeit der Anleihe 2012/17

Unternehmensmitteilung für den Kapitalmarkt Wien (pta009/07.08.2017/09:00) - Die Sanochemia Pharmazeutika AG, Wien (ISIN AT0000776307, ISIN DE000A1G7JQ9) gibt bekannt, dass die Anleihe 2012/17 in H.....

SANOCHEMIA: Veröffentlichte Daten bestätigen Vorteil von Tolperison im Vergleich zu anderen Muskelrelaxans - Anleihenews

Bad Marienberg - Sanochemia Pharmazeutika AG, Wien (ISIN AT0000776307/ WKN 919963, Anleihe: ISIN DE000A1G7JQ9/ WKN A1G7JQ) gibt die Veröffentlichung einer klinischen Studie im Saudi Pharmaceutical .....

Sanochemia-Anleihe 2012/17 vollständig ausbezahlt

Die börsennotierte Sanochemia Pharmazeutika AG hat die Anleihe 2012/17 in Höhe von 10 Millionen Euro, endfällig zum 6. August 2017, vollständig ausbezahlt. Nach dem im Dezember 2016 durchgeführte...

PTA-News: SANOCHEMIA Pharmazeutika AG: Veröffentlichte Daten bestätigen den Vorteil von Tolperison im Vergleich zu anderen Muskelrelaxans

Unternehmensmitteilung für den Kapitalmarkt Wien (pta022/18.07.2017/13:12) - Kürzlich veröffentlichte Daten bestätigen den Vorteil von Tolperison im Vergleich zu einem anderen Muskelrelaxans bei P...

Sanochemia Pharmazeutika AG SAC Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 18052017] Prices from USD $250

SummarySanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and ...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 5% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 5%. ALBUMIN (HUMAN) 5% For intravenous...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 20% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 20%. ALBUMIN (HUMAN) 20% For intraven...

Albumin (human) [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.]

These highlights do not include all the information needed to use ALBUMIN (HUMAN) 25% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 25%. ALBUMIN (HUMAN) 25% For intraven...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Gerot Pharmazeutika

1948 Gerot Pharmazeutika is founded by two chemists, Dr. Gergely and Dr. Otto. 1952 First patent granted on the newly developed product Epilan. 1965 Start of the production and sales of X-ray con...

More Information about "Gerot Pharmazeutika" on BioPortfolio

We have published hundreds of Gerot Pharmazeutika news stories on BioPortfolio along with dozens of Gerot Pharmazeutika Clinical Trials and PubMed Articles about Gerot Pharmazeutika for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gerot Pharmazeutika Companies in our database. You can also find out about relevant Gerot Pharmazeutika Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...


Corporate Database Quicklinks



Searches Linking to this Company Record